Li Dangsheng, Li Tong, Wang Fang, Tian Heather, Samuels Herbert H
Department of Pharmacology, New York University School of Medicine, New York, New York 10016, USA.
Mol Cell Biol. 2002 Aug;22(16):5782-92. doi: 10.1128/MCB.22.16.5782-5792.2002.
Many members of the thyroid hormone/retinoid receptor subfamily (type II nuclear receptors) function as heterodimers with the retinoid X receptor (RXR). In heterodimers which are referred to as permissive, such as peroxisome proliferator activated receptor/RXR, both partners can bind cognate ligands and elicit ligand-dependent transactivation. In contrast, the thyroid hormone receptor (TR)/RXR heterodimer is believed to be nonpermissive, where RXR is thought to be incapable of ligand binding and is often referred to as a silent partner. In this report, we used a sensitive derepression assay system that we developed previously to reexamine the TR/RXR interrelationship. We provide functional evidence suggesting that in a TR/RXR heterodimer, the RXR component can bind its ligand in vivo. Ligand binding by RXR does not appear to directly activate the TR/RXR heterodimer; instead, it leads to a (at least transient or dynamic) dissociation of a cellular inhibitor(s)/corepressor(s) from its TR partner and thus may serve to modulate unliganded TR-mediated repression and/or liganded TR-mediated activation. Our results argue against the current silent-partner model for RXR in the TR/RXR heterodimer and reveal an unexpected aspect of cross regulation between TR and RXR.
甲状腺激素/类视黄醇受体亚家族(II型核受体)的许多成员与类视黄醇X受体(RXR)形成异源二聚体发挥作用。在被称为允许性的异源二聚体中,如过氧化物酶体增殖物激活受体/RXR,两个伙伴都可以结合同源配体并引发配体依赖性反式激活。相比之下,甲状腺激素受体(TR)/RXR异源二聚体被认为是非允许性的,其中RXR被认为无法结合配体,通常被称为沉默伙伴。在本报告中,我们使用了我们之前开发的灵敏的去阻遏检测系统来重新审视TR/RXR的相互关系。我们提供的功能证据表明,在TR/RXR异源二聚体中,RXR组分在体内可以结合其配体。RXR的配体结合似乎不会直接激活TR/RXR异源二聚体;相反,它会导致一种细胞抑制剂/共抑制因子与其TR伙伴发生(至少是短暂的或动态的)解离,因此可能有助于调节未结合配体的TR介导的抑制和/或结合配体的TR介导的激活。我们的结果与目前关于TR/RXR异源二聚体中RXR的沉默伙伴模型相悖,并揭示了TR和RXR之间交叉调节的一个意想不到的方面。